Associations Between Pain Scores and Opioid Doses With Emergency Department Disposition and Return Visit Rates in Children With Sickle Cell Disease
- PMID: 40318215
- DOI: 10.1002/pbc.31750
Associations Between Pain Scores and Opioid Doses With Emergency Department Disposition and Return Visit Rates in Children With Sickle Cell Disease
Abstract
Rapid treatment and frequent reassessment of pain are key components of treatment guidelines for acute sickle cell disease (SCD) pain. Few studies, however, report the associations between emergency department (ED) pain scores, number of ED opioid doses, receipt of an opioid prescription, ED visit disposition, or ED return visits. This seven-site retrospective cohort study analyzed 4983 ED visits by children with SCD pain using electronic health record data from the Pediatric Emergency Care Applied Research Network Registry. ED pain scores included initial, last, and change in scores (initial minus last), measured on a 0-10 scale. Dispositions of discharge and hospital admission were included. Modified Poisson regression and the Cochran-Armitage test of trend were used for analysis. The median (IQR) initial pain score was 8.0 (6-10); last pain score was 5.0 (2-8); and median decrease was 2.0 (0-5). In multivariable analysis, last pain score was the best predictor of disposition. For the return visit analyses, of the 2377 visits discharged at index ED visit, 29% returned within 14 days. Higher initial and last ED pain scores were associated with increased return visits. Children with no opioid discharge prescription and ≥3 ED opioid doses had a return visit rate of 36% compared to 22% if the child received an opioid prescription and only one ED opioid. Increasing discharge opioid prescriptions and targeting interventions for those who receive multiple ED opioid doses could decrease return visits.
Keywords: emergency department; pain score; sickle cell.
© 2025 Wiley Periodicals LLC.
Similar articles
-
Association Between Inadequate Pain Control and Emergency Department Utilization in Trauma Patients.J Surg Res. 2025 Jul;311:241-249. doi: 10.1016/j.jss.2025.04.033. Epub 2025 May 28. J Surg Res. 2025. PMID: 40440881
-
Trends in pain management of sickle cell disease patients presenting with acute vasoocclusive crises: a multi-center retrospective study in Saudi Arabia.Ann Saudi Med. 2025 May-Jun;45(3):190-197. doi: 10.5144/0256-4947.2025.190. Epub 2025 Jun 5. Ann Saudi Med. 2025. PMID: 40482191 Free PMC article.
-
Can Patient-centered Education and Pain Management Delivered by Coaches Improve Pain Outcomes After Orthopaedic Trauma? A Randomized Trial.Clin Orthop Relat Res. 2024 Oct 1;482(10):1858-1869. doi: 10.1097/CORR.0000000000003121. Epub 2024 May 15. Clin Orthop Relat Res. 2024. PMID: 38843502 Clinical Trial.
-
Inhaled nitric oxide for treating pain crises in people with sickle cell disease.Cochrane Database Syst Rev. 2022 Jul 8;7(7):CD011808. doi: 10.1002/14651858.CD011808.pub3. Cochrane Database Syst Rev. 2022. PMID: 35802341 Free PMC article.
-
Intramuscular versus oral corticosteroids to reduce relapses following discharge from the emergency department for acute asthma.Cochrane Database Syst Rev. 2018 Jun 2;6(6):CD012629. doi: 10.1002/14651858.CD012629.pub2. Cochrane Database Syst Rev. 2018. PMID: 29859017 Free PMC article.
References
-
- D. C. Brousseau, J. A. Panepinto, M. Nimmer, et al., “The Number of People With Sickle‐Cell Disease in the United States: National and State Estimates,” American Journal of Hematology 85, no. 1 (2010): 77–78.
-
- K. L. Hassell, “Population Estimates of Sickle Cell Disease in the US,” American Journal of Preventive Medicine 38, no. 4 suppl (2010): S512–S521.
-
- A. M. Brandow, K. J. Zappia, and C. L. Stucky, “Sickle Cell Disease: A Natural Model of Acute and Chronic Pain,” Pain 158, no. Suppl 1 (2017): S79–S84.
-
- K. Kidwell, C. Albo, M. Pope, et al., “Characteristics of Sickle Cell Patients With Frequent Emergency Department Visits and Hospitalizations,” PLOS One 16, no. 2 (2021): e0247324, https://doi.org/10.1371/journal.pone.0247324.
-
- E. R. Meier and J. L. Miller, “Sickle Disease in Children,” Drugs 72, no. 7 (2012): 895–906.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical